| id: |
subject id |
| age: |
age in years at the detection of MGUS |
| sex: |
male or female |
| dxyr: |
year of diagnosis |
| pcdx: |
for subjects who progress to a plasma cell malignancy |
| |
the subtype of malignancy: multiple myeloma (MM) is the |
| |
most common, followed by amyloidosis (AM), macroglobulinemia (MA), |
| |
and other lymphprolifative disorders (LP) |
| pctime: |
days from MGUS until diagnosis of a plasma cell malignancy |
| futime: |
days from diagnosis to last follow-up |
| death: |
1= follow-up is until death |
| alb: |
albumin level at MGUS diagnosis |
| creat: |
creatinine at MGUS diagnosis |
| hgb: |
hemoglobin at MGUS diagnosis |
| mspike: |
size of the monoclonal protein spike at diagnosis |
| |